Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A Systematic Review

被引：46

作者：

Acosta Felquer, Maria Laura ^{[1
]}

Coates, Laura C. ^{[2
]}

Soriano, Enrique R. ^{[3
]}

Ranza, Roberto ^{[4
]}

Espinoza, Luis R. ^{[5
]}

Helliwell, Philip S. ^{[6
]}

FitzGerald, Oliver ^{[7
,8
]}

McHugh, Neil ^{[9
]}

Roussou, Euthalia ^{[10
,11
]}

Mease, Philip J. ^{[12
]}

机构：

[1] Hosp Italiano Buenos Aires, Serv Clin Med, Secc Reumatol, Buenos Aires, DF, Argentina

[2] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England

[3] Hosp Italiano Buenos Aires, Serv Clin Med, Secc Reumatol, Caba, Argentina

[4] Univ Fed Uberlandia, Acad Unit Rheumatol, BR-38400 Uberlandia, MG, Brazil

[5] Louisiana State Univ, Hlth Sci Ctr, Rheumatol Sect, New Orleans, LA USA

[6] Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds, W Yorkshire, England

[7] Univ Coll Dublin, St Vincents Univ Hosp, Dept Rheumatol, Dublin 2, Ireland

[8] Univ Coll Dublin, Conway Inst Biomol Res, Dublin 2, Ireland

[9] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England

[10] Barking Havering & Redbridge Univ, NHS Trust, Barking, Essex, England

[11] Queens Marys Univ London, London, England

[12] Univ Washington, Sch Med, Swedish Med Ctr, Seattle, WA USA

来源：

JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 11期

关键词：

NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BIOLOGICS; DISEASE MODIFYING ANTIRHEUMATIC DRUGS; THERAPEUTIC STRATEGIES; TUMOR NECROSIS FACTOR INHIBITORS; ORAL PHOSPHODIESTERASE-4 INHIBITOR; PLACEBO-CONTROLLED TRIAL; GENERALIZED PUSTULAR PSORIASIS; RANDOMIZED CONTROLLED-TRIAL; TERM 52-WEEK IMPROVEMENT; REQUIRING 2ND-LINE DRUGS; P40; MONOCLONAL-ANTIBODY; NECROSIS FACTOR THERAPY; LOW-DOSE INFLIXIMAB; DOUBLE-BLIND;

D O I：

10.3899/jrheum.140876

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.

引用

页码：2277 / 2285

页数：9

共 71 条

[1] Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Antoni, C
Krueger, GG
de Vlam, K
Birbara, C
Beutler, A
Guzzo, C
Zhou, B
Dooley, LT
Kavanaugh, A
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) : 1150 - 1157
[2] Open-label study of infliximab treatment for psoriatic arthritis: Clinical and magnetic resonance imaging measurements of reduction of inflammation
Antoni, C
Dechant, C
Lorenz, PDHM
Wendler, J
Ogilvie, A
Lueftl, M
Kalden-Nemeth, D
Kalden, JR
Manger, B
[J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (05): : 506 - 512
[3] Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)
Antoni, CE
Kavanagh, A
Kirkham, B
Tutuncu, Z
Burmester, GR
Schneider, U
Furst, DE
Molitor, J
Keystone, E
Gladman, D
Manger, B
Wassenberg, S
Weier, R
Wallace, DJ
Weisman, MH
Kalden, JR
Smolen, J
[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (04): : 1227 - 1236
[4] Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study
Atzeni, Fabiola
Boccassini, Laura
Antivalle, Marco
Salaffi, Fausto
Sarzi-Puttini, Piercarlo
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (04) : 712 - U210
[5] GENERALIZED PUSTULAR PSORIASIS - A CLINICAL AND EPIDEMIOLOGICAL STUDY OF 104 CASES
BAKER, H
RYAN, TJ
[J]. BRITISH JOURNAL OF DERMATOLOGY, 1968, 80 (12) : 771 - &
[6] Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
Baranauskaite, Asta
Raffayova, Helena
Kungurov, N. V.
Kubanova, Anna
Venalis, Algirdas
Helmle, Laszlo
Srinivasan, Shankar
Nasonov, Evgeny
Vastesaeger, Nathan
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (04) : 541 - 548
[7] Leflunomide in Psoriatic Arthritis: Results From a Large European Prospective Observational Study
Behrens, Frank
Finkenwirth, Christoph
Pavelka, Karel
Stolfa, Jiri
Sipek-Dolnicar, Alenka
Thaci, Diamant
Burkhardt, Harald
[J]. ARTHRITIS CARE & RESEARCH, 2013, 65 (03) : 464 - 470
[8] Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment
Brenner, M.
Molin, S.
Ruebsam, K.
Weisenseel, P.
Ruzicka, T.
Prinz, J. C.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (04) : 964 - 966
[9] Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs
Cantini, F.
Niccoli, L.
Nannini, C.
Cassara, E.
Pasquetti, P.
Olivieri, I.
Salvarani, C.
[J]. RHEUMATOLOGY, 2008, 47 (06) : 872 - 876
[10] Criteria, Frequency, and Duration of Clinical Remission in Psoriatic Arthritis Patients with Peripheral Involvement Requiring Second-line Drugs
Cantini, Fabrizio
Niccoli, Laura
Nannini, Carlotta
Cassara, Emanuele
Pasquetti, Paolo
Olivieri, Ignazio
Salvarani, Carlo
[J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 : 78 - 80

← 1 2 3 4 5 6 7 8 →